Independent Director · OnKure Therapeutics, Inc. (OKUR)

Isaac Manke, Ph.D director compensation at OnKure Therapeutics: $76.8K

Fiscal year 2025 director compensation for Isaac Manke, Ph.D at OnKure Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 21, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Isaac Manke, Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Isaac’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Isaac Manke, Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

OnKure Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as OnKure Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$60,497$0$16,294$0$76,791
FY2024$14,752—$247,557$0$262,309

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OnKure Therapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001140361-26-015903, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OnKure Therapeutics, Inc. filed document, accession 0001140361-26-015903. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.

Get the OnKure Therapeutics Board Governance Report

$76,791 Isaac Manke, Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

OnKure Therapeutics pays directors a $40,000 cash retainer.

The rest of the OnKure Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Andrew Phillips, Ph.DIndependent Director$103,794
Dr. SaccomanoDirector—
Edward MathersIndependent Director$61,292
Liam Ratcliffe, Ph.DIndependent Director$0
Michael GreyIndependent Director$56,294
Nicholas SaccomanoDirector—
R. Michael CarruthersIndependent Director$71,294
Valerie M. Jansen, M.D., Ph.DIndependent Director$60,294

The full OnKure Therapeutics compensation record

free company brief

This page is one director within OnKure Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order OKUR

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report